Zeller, Thomas http://orcid.org/0000-0003-2704-3871
Funding for this research was provided by:
Universitäts-Herzzentrum Freiburg - Bad Krozingen GmbH
Article History
Received: 21 November 2021
Accepted: 25 November 2021
First Online: 15 February 2022
Declarations
:
: Honoraria received from Abbott Vascular, BIBA Medical, Biotronik, Boston Scientific Corp., Cook Medical, Efemoral, Gore & Associates, Medtronic, Philips-Spectranetics, Shockwave, Veryan. Consulted for Boston Scientific Corp., CSI, Gore & Associates, Medtronic, Veryan, Philips-Intact Vascular, Shockwave, Bayer, Vesper Medical, VentureMed, ANT. Institutional Grants for research, clinical trial, or drug studies received from Bard Peripheral Vascular, Veryan, Biotronik, Cook Medical, Gore & Associates, Medtronic, Philips, Terumo, TriReme, Shockwave, Med Alliance, Intact Vascular, B. Braun; CSI, Boston Scientific, University of Jena, Pluristem, Philips, PQ Bypass. Common stock: QT Medical.
: For this commentary, formal consent is not required.
: For this commentary, informed consent is not required.
: For this commentary, consent for publication is not required.